Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, Mathilde Varret, Mathilde Di-Filippo Charcosset, Bertrand Cariou, René Valero, Sybil Charriere, Michel Farnier, Pierre E Morange, Olivier Meilhac, Gilles Lambert, Philippe Moulin, Philippe Gillery, Sophie Beliard-Lasserre, Eric Bruckert, Alain Carrié, Jean Ferrières, Xavier Collet, M John Chapman, Eduardo Anglés-Cano
Lipoprotein(a) is an apolipoprotein B100-containing low-density lipoprotein-like particle that is rich in cholesterol, and is associated with a second major protein, apolipoprotein(a). Apolipoprotein(a) possesses structural similarity to plasminogen but lacks fibrinolytic activity. As a consequence of its composite structure, lipoprotein(a) may: (1) elicit a prothrombotic/antifibrinolytic action favouring clot stability; and (2) enhance atherosclerosis progression via its propensity for retention in the arterial intima, with deposition of its cholesterol load at sites of plaque formation...
November 25, 2021: Archives of Cardiovascular Diseases